Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Basel Medical Group Ltd
Insider Yang Xinwen of Basel Medical Group Ltd has filed an initial statement of beneficial ownership of securities via Form 3. This filing serves as the official disclosure of the executive's equity holdings.…more
Basel Medical Group Ltd
Basel Medical Group Ltd closed a registered direct offering on October 9, 2026, raising US$7.98 million in gross proceeds by issuing 6 million units at US$1.33 per unit. The offering increased the total outstanding shares from 1,582,111 to 7,582,111 and included 6 million common warrants exercisable at US$1.463 per share. The company intends to use the net proceeds of approximately US$7.28 million for working capital and potential mergers and acquisitions.…more
Basel Medical Group Ltd
Basel Medical Group announced a registered direct offering of 6 million units at a public offering price of $1.33 per unit, aiming to raise $7.98 million in gross proceeds. Each unit consists of one ordinary share (or one pre-funded warrant) and one common warrant exercisable for one share. The offering will significantly increase the total outstanding shares from 1,582,111 to 7,582,111, leading to substantial shareholder dilution.…more
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Basel Medical Group Closes $7.98 Million Registered Direct Offering
Basel Medical Group has completed a registered direct offering of 6 million units, raising approximately $7.98 million in gross proceeds. The issuance significantly increases the total outstanding shares, leading to potential shareholder dilution.…more
●●●●●●●● ●●●●● ●●●●●●
Basel Medical Group has announced a registered direct offering to raise approximately $7.98 million in gross proceeds. The issuance of new shares and warrants is expected to result in significant dilution for existing shareholders.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.